[Retracted] Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms

Table 1

Primer sequences for quantitative real-time PCR.

Target	Primer sequence (5-3)	Product (bp)
h-GAPDH-F	ACAACTTTGGTATCGTGGAAGG	101
h-GAPDH-R	GCCATCACGCCACAGTTTC
h-TIM3-F	TTGGACATCCAGATACTGGCT	86
h-TIM3-R	CACTGTCTGCTAGAGTCACATTC
h-PDL1-F	TGGCATTTGCTGAACGCATTT	120
h-PDL1-R	TGCAGCCAGGTCTAATTGTTTT
h-LAG3-F	GCCTCCGACTGGGTCATTTT	131
h-LAG3-R	CTTTCCGCTAAGTGGTGATGG
h-CD160-F	GCTGAGGGGTTTGTAGTGTTT	154
h-CD160-R	GTGTGACTTGGCTTATGGTGA
h-CD244-F	TCGTGATTCTAAGCGCACTGT	237
h-CD244-R	CAGGTTCTTGTGACGTGGGAG